Read More Pharma Industry News Ionis Pharmaceuticals moves forward with FDA review of donidalorsen for HAE In a significant development for hereditary angioedema (HAE) patients, Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) announced that the U.S.… byPallavi MadhirajuNovember 4, 2024